• Samsung Bioepis declared an interim cash dividend of KRW 104.31 billion, or KRW 5,043 per common share.
• Payment is scheduled for Dec. 18, 2026, with a Dec. 4 record date.
• Sole shareholder Samsung EPIS Holdings will receive the entire dividend to support financial flexibility and fund business operations.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samsung EPIS Holdings Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261112800691), on November 12, 2026, and is solely responsible for the information contained therein.